Antiepileptogenic complex of albumin with docosahexaenoate

摘要

The infusion of an albumin-docosahexaenoic acid (DHA) complex was shown to inhibit the progression of kindling epileptogenesis. This was shown in mice using kindling as the experimental epilepsy model. The DHA-albumin complex was shown to affect the activity of the brain when administered intraperitoneally. This therapy could also be administered intravenously. This therapy would also be effective against chronic epilepsy.